Schedule of condensed statements of operations and comprehensive loss |
Unaudited condensed statements of operations and comprehensive loss: | | | | | | | | | For the six months ended June 30, | | | 2021 | | 2022 | | | RMB | | RMB | | US$ | Operating expenses: | | | | | | | Selling and marketing expenses | | (18) | | — | | — | General and administrative expenses | | (3,366) | | (2,950) | | (440) | Total operating expenses | | (3,384) | | (2,950) | | (440) | Interest income, net | | 202 | | 55 | | 8 | Equity in loss of subsidiaries, VIEs and subsidiaries of VIEs | | (19,667) | | (53,527) | | (7,991) | Others, net | | 253 | | 256 | | 40 | Net loss | | (22,596) | | (56,166) | | (8,383) | Other comprehensive (loss)/income: | | | | | | | Foreign currency translation adjustments | | (1,603) | | 88 | | 13 | Total comprehensive loss | | (24,199) | | (56,078) | | (8,370) |
|
Schedule of condensed balance sheets |
12. | Additional Information – Condensed Financial Information of the Parent Company (Continued) |
Condensed balance sheets: | | | | | | | | | As of December 31, | | As of June 30, | | | 2021 | | 2022 | | | RMB | | RMB | | US$ | | | | | (Unaudited) | | (Unaudited) | ASSETS | | | | | | | Current assets: | | | | | | | Cash and cash equivalents | | 41,811 | | 10,106 | | 1,509 | Prepayment and other current assets | | 1,016 | | 1,195 | | 178 | Receivables due from subsidiaries, VIEs and subsidiaries of VIEs | | 106,845 | | 113,414 | | 16,932 | Total current assets | | 149,672 | | 124,715 | | 18,619 | Non-current assets: | | | | | | | Investments in subsidiaries, VIEs and subsidiaries of VIEs | | 52,139 | | 27,482 | | 4,103 | Total non-current assets | | 52,139 | | 27,482 | | 4,103 | TOTAL ASSETS | | 201,811 | | 152,197 | | 22,722 | LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | | Current liabilities: | | | | | | | Other taxes payable | | 6,081 | | 6,401 | | 956 | Other current liabilities | | 360 | | 1,673 | | 250 | Total current liabilities | | 6,441 | | 8,074 | | 1,206 | Non-current liabilities: | | | | | | | Other non-current liabilities | | 957 | | 743 | | 110 | Total non-current liabilities | | 957 | | 743 | | 110 | TOTAL LIABILITIES | | 7,398 | | 8,817 | | 1,316 | SHAREHOLDERS’ EQUITY | | | | | | | Class A ordinary shares | | 182 | | 183 | | 28 | Class B ordinary shares | | 35 | | 35 | | 5 | Treasury stock | | (45,886) | | (45,886) | | (6,851) | Additional paid-in capital | | 1,231,135 | | 1,236,179 | | 184,557 | Accumulated deficit | | (983,645) | | (1,039,811) | | (155,240) | Accumulated other comprehensive loss | | (7,408) | | (7,320) | | (1,093) | TOTAL SHAREHOLDERS’ EQUITY | | 194,413 | | 143,380 | | 21,406 | TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | | 201,811 | | 152,197 | | 22,722 |
|
Schedule of condensed statements of cash flows |
Unaudited condensed statements of cash flows: | | | | | | | | | For the six months ended June 30, | | | 2021 | | 2022 | | | RMB | | RMB | | US$ | Net cash used in operating activities | | (531) | | (1,248) | | (186) | Cash flows from investing activities: | | | | | | | Cash paid for investments in subsidiaries, VIEs and subsidiaries of VIEs | | (6,463) | | (31,769) | | (4,743) | Cash received from maturity of time deposits | | 45,674 | | — | | — | Net cash/generated from/(used in) investing activities | | 39,211 | | (31,769) | | (4,743) | Cash flows from financing activities: | | | | | | | Net cash generated from financing activities | | — | | — | | — | Effect of exchange rate changes on cash and cash equivalents | | (880) | | 1,312 | | 196 | Net increase/(decrease) in cash and cash equivalents | | 37,800 | | (31,705) | | (4,733) | Cash and cash equivalents at the beginning of the period | | 46,501 | | 41,811 | | 6,242 | Cash and cash equivalents at the end of the period | | 84,301 | | 10,106 | | 1,509 |
|